Healthcare professionals in the Middle East and North Africa region (MENA) are recommending hydrolysed rice formulas as a first line approach to managing mild-to-moderate cow’s milk allergy in infants.
A systematic review published in the BMJ slams recent formula milk trials as biased, and calls for a “a substantial change” in the way clinical infant formula trials are administered and reported to protect consumers from misinformation.
The Norwegian Scientific Committee for Food and Environment (VKM) says there is insufficient data to recommend a daily intake of the omega-3 oils, Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) for 3-18-year-olds.
Our latest round-up features on new innovations from a2 milk, an infant formula containing novel lipid structure by Danone, to new omega-3 and probiotics launches targeted at infants and young children.
An industry funded observational study of 196 infants has concluded an infant formula containing prebiotic and probiotic ingredients can decrease symptoms of gastro-intestinal disorders within three days.
South Korean firm Navipharm is focusing its R&D efforts on duo-strain probiotics products, after conducting research that appears to show that they are as efficacious, and more cost effective, as compared to multi-strain products.
Bunge has announced its plant-based lipids business, Bunge Loders Croklaan, has launched Betapol Organic, the first China and EU Certified Organic OPO (oleic-palmitic-oleic or SN-2 palmitate) for infant milk formula (IMF).